06 Oct The use of micrografts for the management of stable bilateral vitiligo: the first scientific article.
Posted at 14:12h
in News
From our R&D department we are very proud to announce our first scientific paper regarding the use of Micrografts for the management of Vitiligo.
The aim of this study was to assess the effects of autologous micrografts on patients with bilateral stable vitiligo. Vitiligo is an autoimmune skin disorder characterized by depigmented patches of the skin associated with, among several factors, dysregulation and death of melanocytes.
These outstanding results are suggestive of a potential wide use of autologous micrografts for the treatment of stable vitiligo.
Link:https://pubmed.ncbi.nlm.nih.gov/32954507/
For more information please contact us at: info@rigenerahbw.com